comparemela.com

Latest Breaking News On - Neurology regulatory affairs - Page 1 : comparemela.com

Innodem Neurosciences: ETNA DEVICE FROM THE LEADING DIGITAL HEALTH & AI COMPANY INNODEM NEUROSCIENCES RECEIVES FDA BREAKTHROUGH DESIGNATION FOR MULTIPLE SCLEROSIS

MONTREAL, May 31, 2022 /PRNewswire/ Innodem Neurosciences, a leading provider of innovation and technology for the convergence of neurosciences, digital health, pharmaceutical and artificial

New yorkUnited statesPrnewswire innodem neurosciencesMarc reevesEmbs gmbsKostenloser wertpapierhandelAlyssa howardInnodem neurosciencesTim marjeninUs food drug administrationHead of neurology regulatory affairsClinical research organizationEye movement biomarkers embsMcgill universityBusiness developmentEye tracking neurological assessment

ETNA™ DEVICE FROM THE LEADING DIGITAL HEALTH & AI COMPANY INNODEM NEUROSCIENCES RECEIVES FDA BREAKTHROUGH DESIGNATION FOR MULTIPLE SCLEROSIS

/PRNewswire/ - Innodem Neurosciences, a leading provider of innovation and technology for the convergence of neurosciences, digital health, pharmaceutical and.

Marc reevesEmbs gmbsInnodem neurosciencesTim marjeninUs food drug administrationHead of neurology regulatory affairsEye movement biomarkers embsMcgill universityEye tracking neurological assessmentMultiple sclerosisEye movement biomarkersGaze mapping biomarkersSoftware asa medical deviceVice presidentNeurology regulatory affairsChief business officer

MCRA Expands Neurology Division into Medical Robotics, Exoskeletal and Brain Computer Interface Market

/PRNewswire/ MCRA, LLC, a leading medical device, in-vitro diagnostic, and biologics advisory firm and clinical research organization (CRO) integrating U.S..

New yorkUnited statesAlyssa howardDevjani sahaTim marjeninNeurology regulatory affairsNeurological regulatory affairsOffice of neurologyBreakthrough devices programViscogliosi brothersInternational regulatoryClinical research organizationClinical researchEarly feasibility programSafer technologies program steOffice of clinical evidence

vimarsana © 2020. All Rights Reserved.